Aldeyra Therapeutics ALDX
NASDAQ ALDX
$1.52 +0.02 (+1.33%)
At close: Aug 21, 2026 · 4:00 PM EDT

Aldeyra Therapeutics (ALDX) Amortizatization of Intangibles (2013 - 2026)

Aldeyra Therapeutics' (ALDX) quarterly Amortizatization of Intangibles came in at -$887215.0 in Q4 2025, down 157.7% YoY from $1.5 million in Q4 2024, and down 432.84% on a QoQ basis from $266560.0 in Q3 2025.

Aldeyra Therapeutics (ALDX) Amortizatization of Intangibles (2013 - 2026) Analysis & Trends

Aldeyra Therapeutics (ALDX) has 13 years of Amortizatization of Intangibles data on file, last reported at -$887215.0 in Q4 2025.

  • Quarterly Amortizatization of Intangibles fell 157.7% year-over-year to -$887215.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $151103.0 (down 91.01% YoY) and the FY2025 annual result came in at $218260.0, down 86.94% from the prior year.
  • Amortizatization of Intangibles fell to -$887215.0 in Q4 2025, from $266560.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $1.5 million in Q4 2024 to a low of -$887215.0 in Q4 2025.
  • A 5-year average of $165780.9 and a median of $82799.5 in 2021 frame the typical range for Amortizatization of Intangibles.
  • Annual changes were most pronounced in 2023 — Amortizatization of Intangibles slumped 308.89% — and 2024, when it jumped 536.8%.
  • Tracing ALDX's Amortizatization of Intangibles over 5 years: stood at $82799.0 in 2021, then declined by 0.06% to $82753.0 in 2022, then soared by 310.44% to $339651.0 in 2023, then surged by 352.69% to $1.5 million in 2024, then slumped by 157.7% to -$887215.0 in 2025.
  • The last three Amortizatization of Intangibles figures came in at -$887215.0 (Q4 2025), $266560.0 (Q3 2025), and $771758.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Aldeyra Therapeutics 90.18 Mn 90.18 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 50,368.00
Mar 31, 2026 50,368.00
Dec 31, 2025 -887,215.00
Dec 31, 2025 -887,215.00
Sep 30, 2025 266,560.00
Sep 30, 2025 266,560.00
Jun 30, 2025 771,758.00
Jun 30, 2025 771,758.00
Mar 31, 2025 67,157.00
Mar 31, 2025 67,157.00
Dec 31, 2024 1.54 Mn
Dec 31, 2024 1.54 Mn
Sep 30, 2024 -563,708.00
Sep 30, 2024 -563,708.00
Jun 30, 2024 638,967.00
Jun 30, 2024 638,967.00
Mar 31, 2024 58,152.00
Mar 31, 2024 58,152.00
Dec 31, 2023 339,651.00
Dec 31, 2023 339,651.00